Type 2 Diabetes-Treatment Fails
Type 2 diabetes treatments for both cholesterol and high blood pressure fail to save lives.
Diabetes Type 2 Treatment
Key results from a landmark federal study shows that adding drugs to drive blood pressure and blood-fats lower than current targets, does not prevent heart problems, and in some cases causes harmful side effects.
Study
The study involved people with Type 2 diabetes. Diabetics have more than double the risk of being a heart attack or stoke statistic. Researches led by Columbia University’s Dr. Henry Ginsburg studied more than 5,500 diabetics who also had another health risk, such as high blood pressure or cholesterol.
All were given statin-cholesterol-lowering pills sold as Lipitor and Zocor. Half were also given Abbott Laboratories’ TriCor, and the rest got placebos. TriCor is a drug that lowers fats called triglycerides while boosting “good” cholesterol. People with very high blood fats seemed to have some benefit from TriCor.
Women taking TriCor appeared to have a higher chance to have heart problems compared to the women taking the placebo.
The blood-pressure part of the study was led by Dr. William Cushman, preventive medicine chief at Veterans Affairs Medical Center in Memphis, Tennessee. About 4,700 diabetics were treated with different medicines to keep their systolic blood pressure-the top number-either below 140 or below 120.
The intense treatment did not reduce the number of heart attacks, although it prevented more strokes, a less common problem. Side effects were greater with the intense treatment.
North Chicago, Illinois-based Abbott makes TriCor and a newer version, Trilipix. The drugs had more than $1.3 billion in U.S. sales last year.
The Natural Way
There are natural ways to combat type 2 diabetes, high cholesterol, and high blood pressure. Natural healing is an underutilized intervention. It is both potent and convenient.
The optimal defense is a lifestyle makeover. Lifestyle changes are unmatched and have the potential to turn around chronic conditions such as type 2 diabetes. This is a modality that physicians have not tapped into. This has the ability to prevent drug induced serious conditions. The pharmaceutical companies are still looking for a little green pill, the color of a dollar bill.
Related posts: